CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 134 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3 | -99.9% | 3,800 | +533.3% | 0.00% | – |
Q3 2020 | $4,000 | +100.0% | 600 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 600 | -45.5% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -60.0% | 1,100 | 0.0% | 0.00% | – |
Q3 2019 | $5,000 | -90.2% | 1,100 | -94.3% | 0.00% | -100.0% |
Q2 2019 | $51,000 | +466.7% | 19,400 | +1041.2% | 0.00% | +300.0% |
Q1 2019 | $9,000 | -50.0% | 1,700 | -29.2% | 0.00% | -50.0% |
Q4 2018 | $18,000 | – | 2,400 | -11.1% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 2,700 | -50.0% | 0.00% | – |
Q2 2018 | $5,000 | -58.3% | 5,400 | +315.4% | 0.00% | -100.0% |
Q1 2018 | $12,000 | +200.0% | 1,300 | +44.4% | 0.00% | – |
Q4 2017 | $4,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |